All Type of News
Administration related to clinical trials to be reformed
The Korea Food and Drug Administration has announced that a series of measures will be adopted to reform regulations related to clinical trials.
The drug agency said the screening results of Investigational New Dru...
Once-monthly treatment for diabetes shows promise
A new diabetic medicine developed by a Korean drug maker has been under the first phase of clinical trials in the Netherlands and Korea.
The drug (codename: HM11260C), developed by Hanmi Pharmaceutical, a novel GLP...
KFDA approves Effient, blood-thinning medication
The Korea Food and Drug Administration approved a blood-thinning drug Effient tablets (prasugrel), co-developed by Eli-Lilly and Daiich Sankyo, on July 29 to reduce the risk of blood clots from forming in patients who...
Pharmacy student quota triggers debate
The Association of Korean Pharmacy School Students said that the government should provide the rationale of 390 new pharmacy student quotas and 15 newly established pharmacy schools across the region.
The associati...
Korea to develop protein based medicines
The government plans to develop a set of premier materials such as protein based drugs, which it expects will become the norms of the global markets in the not-so-distant future.
The Ministry of Knowledge Economy (...
Vaccines make Green Cross No. 4 drugmaker
Green Cross became the fourth-biggest drug manufacturer in Korea in terms of quarterly revenue, as the outbreak of Influenza A boosted overseas demand for seasonal flu vaccines.
Green Cross posted revenues of 160 ...
KFDA introduces ‘flexible time’
The Korea Food and Drug Administration says it has implemented its flexible working schedules from this August before its location transfer to Osung, South Choonbuk Province in November.
According to KFDA officials...
Government Oks sale of locally-produced hemophilia A treatment
Korea’s health authorities gave the green light to Green Cross Corp. on August 30 to sell Greengene-F injection, an albumin-free, B-domain deleted (BDD) recombinant human coagulation factor VIIIB domain VIII.
It is...
Hanmi Pharm shares boosted by simplified corporate structure
Shares of Hanmi Pharm were boosted on August 30 by expectations that it split into holding and operating entities to simplify its corporate structure.
Hanmi Pharm shares rose 11 percent to 99,900 won on the Seoul b...
CMC replaces drug supplier
Catholic Medical Center said it has recently signed a supply agreement with two new wholesalers, VivaMedi and Via Davinchi.
CMC officials said the two wholesalers will supply 300 billion worth of medicines to CMC f...
